Member Info for Dracula1

Also, Good to see your sidekick adding his farthing's worth. IMO.

Inanaco. Grow Up. You read It. The SP Is 6P.

Inanaco, Will you Grow Up.

Inanaco, why do you bother to give 12 responses to a post that you don't agree with. Then give recommendations to a person you know very little about. Can I be a little kinder to you and suggest you beef up your Immune system with a dose of reality. Sclp Sp 6P. Thanks Cars a very level headed post on the prospects. Same to you Berm. IMO.

Inanaco/Konar/ Berm, Thanks for the replies. Inanaco with respect . On SCIB1, I believe that you are only making my case stronger with your very well represented examples. All that you have posted that's Happened or Happening, when there Is already a seemingly very good compound In SCIB1 already available. WHY does no Pharma Buy or take a major hold In Sclp. Konar/Berm, I would be of the same opinion of hopefully a Buy out of the Co. I hope there Is. BUT for How much?. IMO.

What's the chances of. Any of Sclp's compounds In say the Next year getting a far better response from Pharmas than SCIB1 got . IMO

When you see a test Kit Co go from circa 18P to £5 that only Informs you If you have a Virus or not. Would a valuation of anything from £1 to say £10 be out of order for a treatment that may cure you. Which In the case of SCIB1 seems to be fairly positive. With the experience and progress that Lady In charge of Sclp's compounds has made. It must be absolutely frustrating at least If not soul destroying to see your achievements not being appreciated by a partnership by a Major Pharma. IMO.

IMO, Politics In USA plays a big Part in Pharma. Especially when you see Hydroxy been promoted . IMO, one of the Major problems with Sclp attracting Cash Investments Is what do you have to prove In any Compound. When you have already produced a Seemingly very useful worthwhile Compound (SCIB1) and Nobody seems to be Interested. So Why would Pharmas be Interested In anything else the Co produces no matter how good It may be. You have to ask why. Would It be a much more successful treatment and a too much more competitively priced Drug IMO. BTW, I'm Invested Long term not a trader.

That a Share In Faron can be bought for £3.20 when the IPO SP was £2.50. Just look at the Progress Both Scientifically and Financially that the Co has made in the last 12 Mths. AIMO.

It's All politics...no matter whether it's about peoples health or any other means of large Co's making money. To see the promotion that Hydroxy got from That Expert. Just shows what Small Bios are up against. IMO.

It's where are the sells coming from. Are they being manufactured by someone to try and create doubt. IMO

Just making the point of what does a Small Bio have to do to attract a Buyer/Partner.

Thanks Ray.

When you read that. Scancell would seem to be a better Co, at least Sclp produced something that worked. But NOT of Value to any Pharma??. When Sclp Produce SCIB1 which seems to have major benefits to mankind. Reading that piece It seems that Biontech hasn't Produced anything that has being approved for Human use. After 20 compounds?. Where does their Profit come from??. Moderna Is mentioned In that article. Did they get £485,000,000 from Government to produce something??. Does It seem that this Coronavirus was a great excuse for a lot of Pharmas??. Feel free to correct me. IMO

Take It away from WHO.

Gave Moderna $483,000,000 to produce a Vaccine.

AFAICR, IF I/m correct Faron have patents on many of the Interferon ways of usage.

Inanaco, let's be realistic DID any Pharma want to buy or Partner SCIB1. It seems that It was successful. You can give all the explanations you want with your knowledge of the science . I'm honest enough to say I know little about the science. In what way will the results of Achilles trial affect SCIB1. Whether It's a good or bad result It will mean nothing to Sclp. Scancell have a good Drug but no body up to today wants It. Read Michaelhighbar's post I would IMO say that's a fairly general opinion on Sclp position at present. Can respect your positive commitment. None of us win unless there Is positives. IMO.

Berm, Would you wonder why Achilles are going ahead with that treatment, after seeing that Scancell got little Interest for SCIB1 after having such good results. Could they not try and do a deal with Scancell for SCIB1. Surely wouldn't be hard to deal with Scancell after SCIB1 sitting there for 4 years. Am I being too simplistic. IMO.

What did I miss?.......Who bought SCIB1.